CoChat

Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York

Open access
West, Anthony P., Wertheim, Joel O., Wang, Jade C., Vasylyeva, Tetyana I., Havens, Jennifer L., Chowdhury, Moinuddin A., Gonzalez, Edimarlyn, Fang, Courtney E., Di Lonardo, Steve S., Hughes, Scott, Rakeman, Jennifer L., Lee, Henry H., Barnes, Christopher O., Gnanapragasam, Priyanthi N. P., Yang, Zhi, Gaebler, Christian, Caskey, Marina, Nussenzweig, Michel C., Keeffe, Jennifer R., Bjorkman, Pamela J. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)

Preprint — published as 10.1038/s41467-021-25168-4 · Paper page

PreprintCited by 50

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Wide-scale SARS-CoV-2 genome sequencing is critical to tracking viral evolution during the ongoing pandemic. Variants first detected in the United Kingdom, South Africa, and Brazil have spread to multiple countries. We developed the software tool, Variant Database (VDB), for quickly examining the changing landscape of spike mutations. Using VDB, we detected an emerging lineage of SARS-CoV-2 in the New York region that shares mutations with previously reported variants. The most common sets of spike mutations in this lineage (now designated as B.1.526) are L5F, T95I, D253G, E484K or S477N, D614G, and A701V. This lineage was first sequenced in late November 2020 when it represented <1% of sequenced coronavirus genomes that were collected in New York City (NYC). By February 2021, genomes from this lineage accounted for ~ 32% of 3288 sequenced genomes from NYC specimens. Phylodynamic inference confirmed the rapid growth of the B.1.526 lineage in NYC, notably the sub-clade defined by the spike mutation E484K, which has outpaced the growth of other variants in NYC. Pseudovirus neutralization experiments demonstrated that B.1.526 spike mutations adversely affect the neutralization titer of convalescent and vaccinee plasma, indicating the public health importance of this lineage.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2021.02.14.431043

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 32

  1. 10.1016/j.cell.2020.06.043 · DOI · Paper page
  2. 10.1101/2020.12.21.20248640 · DOI · Paper page
  3. 10.1101/2021.01.26.21250224 · DOI · Paper page
  4. 10.1038/s41586-021-03324-6 · DOI · Paper page
  5. 2021, Want to track pandemic variants faster? Fix the bioinformatics bottleneck, Nature, 591, 30, 10.1038/d41586-021-00525-x · DOI
  6. Shu, Y. & McCauley, J. GISAID: Global initiative on sharing all influenza data – from vision to reality. Eurosurveillance 22, (2017). · DOI · Paper page
  7. 2021, Evolution of antibody immunity to SARS-CoV-2, Nature, 591, 639, 10.1038/s41586-021-03207-w · DOI · Paper page
  8. 10.1101/2021.02.23.21252268 · DOI · Paper page
  9. 2020, Convergent antibody responses to SARS-CoV-2 in convalescent individuals, Nature, 584, 437, 10.1038/s41586-020-2456-9 · DOI · Paper page
  10. 10.1101/2021.01.14.426475 · DOI · Paper page
  11. 10.1101/2020.10.25.20219063 · DOI · Paper page
  12. 2020, Mutations Strengthened SARS-CoV-2 Infectivity, Journal of Molecular Biology, 432, 5212, 10.1016/j.jmb.2020.07.009 · DOI · Paper page
  13. 10.1101/2020.03.15.991844 · DOI
  14. 10.1093/ve/vey016 · DOI · Paper page
  15. 10.1101/2021.01.12.21249613 · DOI
  16. 10.1101/2021.02.23.21252259 · DOI · Paper page
  17. 10.1101/2021.02.26.21251868 · DOI
  18. 10.1093/molbev/mst010 · DOI · Paper page
  19. 10.1093/molbev/msu300 · DOI · Paper page
  20. 10.1093/bioinformatics/btl529 · DOI · Paper page
  21. 10.1038/nprot.2017.066 · DOI · Paper page
  22. 10.1101/2020.09.04.283077 · DOI · Paper page
  23. 10.1093/bioinformatics/btp324 · DOI · Paper page
  24. 10.1186/s13059-018-1618-7 · DOI · Paper page
  25. 10.1093/bioinformatics/btr509 · DOI · Paper page
  26. 10.1093/biomethods/bpaa014 · DOI · Paper page
  27. 2020, IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era, Mol Biol Evol, 37, 1530, 10.1093/molbev/msaa015 · DOI · Paper page
  28. 10.1093/ve/vex042 · DOI · Paper page
  29. 2018, Poorly Controlled Diabetes in New York City: Mapping High-Density Neighborhoods, Journal of Public Health Management and Practice, 24, 69, 10.1097/PHH.0000000000000544 · DOI
  30. 10.1126/science.abf6840 · DOI · Paper page
  31. 2020, Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays, Viruses, 12, 513, 10.3390/v12050513 · DOI · Paper page
  32. 10.1073/pnas.1309215110 · DOI

Cited by

See all 50

Metadata

Authors
West, A. P., Wertheim, J. O., Wang, J. C., Vasylyeva, T. I., Havens, J. L., Chowdhury, M. A., Gonzalez, E., Fang, C. E., Di Lonardo, S. S., Hughes, S., Rakeman, J. L., Lee, H. H., Barnes, C. O., Gnanapragasam, P. N. P., Yang, Z., Gaebler, C., Caskey, M., Nussenzweig, M. C., Keeffe, J. R., & Bjorkman, P. J.
Venue
bioRxiv (Cold Spring Harbor Laboratory)
Publisher
openRxiv
Published
2021-02-15
OpenAlex
W3133148178
Cited by
50
References
11
Type
posted content
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York. https://app.cochat.ai/papers/10.1101/2021.02.14.431043
The paper
West, A. P., Wertheim, J. O., Wang, J. C., Vasylyeva, T. I., Havens, J. L., Chowdhury, M. A., Gonzalez, E., Fang, C. E., Di Lonardo, S. S., Hughes, S., Rakeman, J. L., Lee, H. H., Barnes, C. O., Gnanapragasam, P. N. P., Yang, Z., Gaebler, C., Caskey, M., Nussenzweig, M. C., Keeffe, J. R., & Bjorkman, P. J. (2021). Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York. bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/2021.02.14.431043

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.